MetLife, Inc. (NYSE:MET) Shares Sold by Abbrea Capital LLC

Abbrea Capital LLC cut its stake in MetLife, Inc. (NYSE:METGet Rating) by 4.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,892 shares of the financial services provider’s stock after selling 220 shares during the quarter. Abbrea Capital LLC’s holdings in MetLife were worth $306,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Ingalls & Snyder LLC acquired a new stake in shares of MetLife during the 3rd quarter worth about $205,000. WINTON GROUP Ltd increased its position in shares of MetLife by 76.1% during the 3rd quarter. WINTON GROUP Ltd now owns 14,758 shares of the financial services provider’s stock worth $911,000 after purchasing an additional 6,376 shares during the last quarter. Community Bank N.A. increased its position in shares of MetLife by 300.0% during the 3rd quarter. Community Bank N.A. now owns 800 shares of the financial services provider’s stock worth $49,000 after purchasing an additional 600 shares during the last quarter. Intrua Financial LLC increased its position in shares of MetLife by 13.2% during the 3rd quarter. Intrua Financial LLC now owns 6,002 shares of the financial services provider’s stock worth $386,000 after purchasing an additional 701 shares during the last quarter. Finally, 180 Wealth Advisors LLC increased its position in shares of MetLife by 2.4% during the 3rd quarter. 180 Wealth Advisors LLC now owns 25,906 shares of the financial services provider’s stock worth $1,699,000 after purchasing an additional 619 shares during the last quarter. 88.85% of the stock is owned by institutional investors and hedge funds.

MET stock traded up $0.70 during trading on Monday, hitting $71.34. 123,297 shares of the company’s stock were exchanged, compared to its average volume of 4,700,582. The business has a 50-day moving average price of $68.64 and a two-hundred day moving average price of $65.58. The stock has a market capitalization of $58.86 billion, a price-to-earnings ratio of 9.67, a PEG ratio of 1.33 and a beta of 1.18. MetLife, Inc. has a 52-week low of $55.21 and a 52-week high of $72.55. The company has a current ratio of 0.14, a quick ratio of 0.14 and a debt-to-equity ratio of 0.22.

MetLife (NYSE:METGet Rating) last posted its earnings results on Wednesday, February 2nd. The financial services provider reported $2.17 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.75. The firm had revenue of $20.21 billion during the quarter, compared to analysts’ expectations of $17.67 billion. MetLife had a return on equity of 11.96% and a net margin of 9.22%. The firm’s revenue was down 1.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.03 earnings per share. On average, equities research analysts anticipate that MetLife, Inc. will post 7.14 earnings per share for the current fiscal year.

In other MetLife news, EVP Steven J. Goulart sold 56,857 shares of MetLife stock in a transaction that occurred on Tuesday, February 8th. The stock was sold at an average price of $70.29, for a total transaction of $3,996,478.53. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.20% of the company’s stock.

A number of equities analysts recently commented on the company. Evercore ISI upgraded MetLife from an “in-line” rating to an “outperform” rating and raised their target price for the company from $67.00 to $75.00 in a report on Wednesday, January 5th. JPMorgan Chase & Co. raised their target price on MetLife from $69.00 to $75.00 in a report on Tuesday, April 5th. Jefferies Financial Group assumed coverage on MetLife in a report on Tuesday, January 25th. They set a “buy” rating and a $74.00 target price for the company. Wells Fargo & Company lowered their target price on MetLife from $75.00 to $74.00 and set an “overweight” rating for the company in a report on Tuesday, January 4th. Finally, Piper Sandler raised their target price on MetLife from $77.00 to $80.00 and gave the company an “overweight” rating in a report on Wednesday, April 6th. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $74.14.

MetLife Company Profile (Get Rating)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METGet Rating).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.